It was reported yesterday that GreenLight Biosciences Inc, a bio-performance company developing RNA-based solutions for agriculture and pharmaceutical applications, has named Susan Keefe as its new chief financial officer.
The new chief financial officer is to lead the company's financial strategy and facilitate its growth plan, and will be responsible for managing all aspects of GreenLight's financial operations.
Prior to joining GreenLight, Keefe worked for 25 years in financial positions across the biotech, consumer packaged goods and health care industries. Most recently, she served as financial consultant to a range of life science companies with Danforth Advisors.
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers
INOVIO announces inducement grant to new employee
AbbVie's Allergan Aesthetics announces Natrelle supplier agreement with Vizient
Karyopharm Therapeutics awards inducement grants to new employees
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar
Novo Nordisk expands legal action over compounded 'semaglutide'
Neuraxpharm launches Neuraxpharm Australia
OncoZenge selects Meribel Pharma as CDMO for Phase 3 BupiZenge project
Fridays nominated for World Out of Home awards for weight loss campaign